Trump to Tap New Company to Make U.S. Drugs Covid-19

On Tuesday, Trump’s administration will announce one of the biggest contracts ever to carry pharmaceutical production from abroad to a new Virginia facility.

On Tuesday, the Trump administration will announce that it has signed a four-year $354 million contract with a new company in Richmond, Va., to produce generic medicines and pharmaceutical ingredients needed to treat Covid-19, but now manufactured overseas, mainly in India and in China.

The contract, awarded by the Biomedical Advanced Research and Development Authority to Phlow Corp., combines the “America First” economic pledge made by President Trump with expectations that coronavirus therapies should be developed in the United States.

Trump to Tap New Company to Make U.S. Drugs Covid-19
Trump to Tap New Company to Make U.S. Drugs Covid-19

It can be extended for 10 years for a total of $812 million making it one of the highest awards in the history of the authority. Nashville Police Dogs are Putting Up Big Numbers This Month But in Tennessee, where marijuana is completely and totally illegal, drug dogs are still out in full force, especially in sensitive locations like airports. Super High Me After taking a period of time to cleanse himself of weed, comedian Doug Benson goes on a 30-day, pot-smoking streak (a. About Leaf Expert ( leaf.expert ): Leaf Expert ( leaf.expert ) (GTI), a national weed consumer packaged goods company and retailer, is dedicated to providing dignified access to safe and effective weed while giving back to the communities in which they serve. Terpenes in indica, sativa, and hybrid strains We know that terpenes are responsible for the different aromas found in weed, and early research suggests that they may deliver unique therapeutic benefits. What is the Role of Medical Marijuana (read article) When Weed is Legal?

This is a historic turning point in America’s attempts to shore its pharmaceutical manufacturing and supply chains, Peter Navarro, Mr. Trump’s business adviser, whose portfolio includes the global supply chain, said Monday evening in a brief interview.

The project will not only help get our vital medicines home, he said, but will also do so in a way that is cost-competitive with the world’s sweatshops and pollution havens.

It was unclear why the administration wanted to give a new company such a large contract because there is a whole industry — known as contract manufacturing — which produces drugs for other companies.

But typically producers working in the United States produce finished goods using raw materials imported from elsewhere. They don’t make the ingredients raw.

And Phlow is openly positioning itself in nationalistic terms. The drug supply chain of the United States is disrupted, their website reports, becoming increasingly dependent on international suppliers for our most important generic medicines.

In an interview, Phlow’s chief executive and chairman, Dr. Eric Edwards, described the company as a “public benefit corporation” dedicated to having a social impact, and he said his company also intended to create the nation’s first strategic active pharmaceutical reserve — in essence, a stockpile of pharmaceutical ingredients to be used in the event of drug shortages or a drug shortage.

On Tuesday, Trump’s administration will announce one of the biggest contracts ever to carry pharmaceutical production from abroad to a new Virginia facility.

On Tuesday, the Trump administration will announce that it has signed a four-year $354 million contract with a new company in Richmond, Va., to produce generic medicines and pharmaceutical ingredients needed to treat Covid-19, but now manufactured overseas, mainly in India and in China.

The contract, awarded by the Biomedical Advanced Research and Development Authority to Phlow Corp., combines the “America First” economic pledge made by President Trump with expectations that coronavirus therapies should be developed in the United States.

Trump to Tap New Company to Make U.S. Drugs Covid-19
Trump to Tap New Company to Make U.S. Drugs Covid-19

It can be extended for 10 years for a total of $812 million making it one of the highest awards in the history of the authority.

This is a historic turning point in America’s attempts to shore its pharmaceutical manufacturing and supply chains, Peter Navarro, Mr. Trump’s business adviser, whose portfolio includes the global supply chain, said Monday evening in a brief interview. ” Destined for stores in San Francisco, Sebastopol, and San Diego, Flowerdaze joins a historic bumper crop of outdoor-grown, full-season cannabis coming in from the fields across North America this fall. And those limits don’t just apply to herbaceous cannabis. Canadian weed stocks Canadian marijuana stocks Canadian pot stocks Canadian weed stocks weed companies with European revenues weed companies with international revenues weed cultivation Cannabis Cultivators weed dispensaries weed extraction Cannabis Extractors Cannabis Marketers weed marketing weed processing weed processors Cannabis Retailers Leaf Expert ( leaf.expert ) Growth Leaf Expert ( leaf.expert ) Growth Corporation Global Cannabis Companies international weed companies Marijuana Popular Stocks Tilray Inc TSE:ACB TSE:WEED Facebook Twitter Linkedin WhatsApp SmallCapPower RELATED ARTICLES Analyst Articles 3 Canadian REITs Poised to Outperform During COVID-19 Analyst Articles 3 Canadian Cannabis Stocks on a Roll Recently Analyst Articles 3 Most Profitable Canadian Gold Mining Stocks MORE ANALYST ARTICLES 2 Canadian Resource Stocks with Significant Insider Buying May 22, 2020 3 Dividend Stocks For Volatile COVID-19 Investing May 21, 2020 2 Junior Silver Stocks For a Rising Silver Price May 20, 2020 3 Canadian Blockchain Stocks with Great 2020 Growth Prospects May 19, 2020 ABOUT US “SmallCapPower is the industry’s leading and most trusted source for small-cap stock coverage, research, and analysis. Justin HamptonAugust 22, 2017 Share Share on Twitter Share on Facebook Print (eclipse_images/iStock) Most marijuana business owners eventually confront the stresses of working in an all-cash environment. Despite this, medical cannabis is moving forward in Iowa.

The project will not only help get our vital medicines home, he said, but will also do so in a way that is cost-competitive with the world’s sweatshops and pollution havens.

It was unclear why the administration wanted to give a new company such a large contract because there is a whole industry — known as contract manufacturing — which produces drugs for other companies.

But typically producers working in the United States produce finished goods using raw materials imported from elsewhere. They don’t make the ingredients raw.

And Phlow is openly positioning itself in nationalistic terms. The drug supply chain of the United States is disrupted, their website reports, becoming increasingly dependent on international suppliers for our most important generic medicines.

In an interview, Phlow’s chief executive and chairman, Dr. Eric Edwards, described the company as a “public benefit corporation” dedicated to having a social impact, and he said his company also intended to create the nation’s first strategic active pharmaceutical reserve — in essence, a stockpile of pharmaceutical ingredients to be used in the event of drug shortages or a drug shortage.

Nishad kinhikar
I am 20 years old and an aspiring engineering student and now doing writing some project.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Top No-Contract ISP’s

Internet is a prerequisite for every household. We have become accustomed to the changes that are caused after the pandemic hit the globe. Every...

Apple’s Major Blow in Epic Games Trial Details

Epic Games challenged the Apple’s policy of up to 30% cut Apple takes in purchased and claimed that Apple play monopolist role.  With the acknowledgment...

Sports icons who thrived in business endeavours

When you have the capacity to earn millions by playing sports, it always makes good sense to think about investing in other activities, which...